Literature DB >> 19153653

The role of microRNAs in metastasis and epithelial-mesenchymal transition.

C P Bracken1, P A Gregory, Y Khew-Goodall, G J Goodall.   

Abstract

For a tumour cell to metastasize it must successfully negotiate a number of events, requiring a series of coordinated changes in the expression of many genes. MicroRNAs are small non-coding RNA molecules that post-transcriptionally control gene expression. As microRNAs are now recognised as master regulators of gene networks and play important roles in tumourigenesis, it is no surprise that microRNAs have recently been demonstrated to have central roles during metastasis. Recent work has also demonstrated critical roles for microRNAs in epithelial-mesenchymal transition, a phenotypic change underlain by altered gene expression patterns that is believed to mirror events in metastatic progression. These findings offer new potential for improved prognostics through expression profiling and may represent novel molecular treatment targets for future therapy. In this review, we summarise the multistep processes of metastasis and epithelial-mesenchymal transition and describe the recent discoveries of microRNAs that participate in controlling these processes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19153653     DOI: 10.1007/s00018-009-8750-1

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  59 in total

1.  A microRNA that limits metastatic colonisation and endothelial recruitment.

Authors:  Yeesim Khew-Goodall; Gregory J Goodall
Journal:  EMBO J       Date:  2012-02-15       Impact factor: 11.598

2.  MicroRNA-590-5p regulates proliferation and invasion in human hepatocellular carcinoma cells by targeting TGF-β RII.

Authors:  Xiaofeng Jiang; Guangyang Xiang; Yezeng Wang; Lei Zhang; Xuewei Yang; Liangqi Cao; Heping Peng; Ping Xue; De Chen
Journal:  Mol Cells       Date:  2012-06-07       Impact factor: 5.034

Review 3.  microRNAs and EMT in mammary cells and breast cancer.

Authors:  Josephine A Wright; Jennifer K Richer; Gregory J Goodall
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-05-25       Impact factor: 2.673

Review 4.  Epigenetic regulation of epithelial-mesenchymal transition.

Authors:  Lidong Sun; Jia Fang
Journal:  Cell Mol Life Sci       Date:  2016-07-08       Impact factor: 9.261

5.  Complete reversal of epithelial to mesenchymal transition requires inhibition of both ZEB expression and the Rho pathway.

Authors:  Shreyas Das; Bryan N Becker; F Michael Hoffmann; Janet E Mertz
Journal:  BMC Cell Biol       Date:  2009-12-21       Impact factor: 4.241

6.  A novel microRNA regulator of prostate cancer epithelial-mesenchymal transition.

Authors:  Nathan Bucay; Divya Bhagirath; Kirandeep Sekhon; Thao Yang; Shinichiro Fukuhara; Shahana Majid; Varahram Shahryari; ZLaura Tabatabai; Kirsten L Greene; Yutaka Hashimoto; Marisa Shiina; Soichiro Yamamura; Yuichiro Tanaka; Guoren Deng; Rajvir Dahiya; Sharanjot Saini
Journal:  Cell Death Differ       Date:  2017-05-12       Impact factor: 15.828

7.  Targets of the tumor suppressor miR-200 in regulation of the epithelial-mesenchymal transition in cancer.

Authors:  Mark J Schliekelman; Don L Gibbons; Vitor M Faca; Chad J Creighton; Zain H Rizvi; Qing Zhang; Chee-Hong Wong; Hong Wang; Christin Ungewiss; Young-Ho Ahn; Dong-Hoon Shin; Jonathan M Kurie; Samir M Hanash
Journal:  Cancer Res       Date:  2011-10-10       Impact factor: 12.701

Review 8.  The rise of regulatory RNA.

Authors:  Kevin V Morris; John S Mattick
Journal:  Nat Rev Genet       Date:  2014-04-29       Impact factor: 53.242

9.  miR-200 enhances mouse breast cancer cell colonization to form distant metastases.

Authors:  Derek M Dykxhoorn; Yichao Wu; Huangming Xie; Fengyan Yu; Ashish Lal; Fabio Petrocca; Denis Martinvalet; Erwei Song; Bing Lim; Judy Lieberman
Journal:  PLoS One       Date:  2009-09-29       Impact factor: 3.240

10.  Role for DNA methylation in the regulation of miR-200c and miR-141 expression in normal and cancer cells.

Authors:  Lukas Vrba; Taylor J Jensen; James C Garbe; Ronald L Heimark; Anne E Cress; Sally Dickinson; Martha R Stampfer; Bernard W Futscher
Journal:  PLoS One       Date:  2010-01-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.